.webp)
The global senolytics and anti-aging pharmaceuticals market size was estimated at USD 4.18 billion in 2024 and is predicted to increase from USD 4.50 billion in 2025 to approximately USD 8.72 billion by 2034, expanding at a CAGR of 7.63% from 2025 to 2034. The growth of the market is driven by the rising research activities aimed at understanding aging and senescence. Furthermore, the rising demand for solutions to avoid the degenerative processes of aging and associated chronic diseases drives the growth of the market.
The global pet herbal supplements market size was estimated at USD 1.07 billion in 2024 and is predicted to increase from USD 1.18 billion in 2025 to approximately USD 2.96 billion by 2034, expanding at a CAGR of 10.71% from 2025 to 2034. The growth of the market is driven by increasing awareness among pet owners about natural and holistic health solutions for their pets.
The global herceptin market size accounted for USD 3.26 billion in 2024 and is predicted to increase from USD 3.44 billion in 2025 to approximately USD 5.61 billion by 2034, expanding at a CAGR of 5.58% from 2025 to 2034. The market growth is driven by the growing number of HER2-positive cancer patients, rising acceptance of precision medicine, and expanding global healthcare systems.
The global federated learning in healthcare market size accounted for USD 30.62 million in 2024 and is predicted to increase from USD 35.67 million in 2025 to approximately USD 141.01 million by 2034, expanding at a CAGR of 16.50% from 2025 to 2034. The market is witnessing significant growth due to the rising concerns about data privacy and security in the healthcare sector. The increasing adoption of AI-based models to transform the delivery of healthcare services by improving diagnosis, treatment, and research further supports market growth.
The global anti-aging supplements market size accounted for USD 4.52 billion in 2024 and is predicted to increase from USD 4.88 billion in 2025 to approximately USD 9.79 billion by 2034, expanding at a CAGR of 8.03% from 2025 to 2034. The aging population and the rapid shift toward natural wellness practices drive the growth of the market.
The U.S. multiple sclerosis drugs market size accounted for USD 7.81 billion in 2024 and is predicted to increase from USD 8.44 billion in 2025 to approximately USD 17.15 billion by 2034, expanding at a CAGR of 8.18% from 2025 to 2034. The growth of the U.S. multiple sclerosis drugs market is driven by the increased prevalence and awareness of multiple sclerosis, the availability of better diagnostic tools, and the rising regulatory approvals for innovative therapies.
The global multiple sclerosis drugs market size accounted for USD 21.26 billion in 2024 and is predicted to increase from USD 22.96 billion in 2025 to approximately USD 45.90 billion by 2034, expanding at a CAGR of 8.00% from 2025 to 2034. The growth of the market is driven by ongoing clinical trials, increasing approvals from regulatory agencies, and rising investments in R&D activities for developing new therapies.
The global measles, mumps, rubella vaccine market size accounted for USD 1.86 billion in 2024 and is predicted to increase from USD 2.02 billion in 2025 to approximately USD 4.21 billion by 2034, expanding at a CAGR of 8.51% from 2025 to 2034. The rising efforts of public health agencies to increase the awareness about benefits of vaccination in communities across the world is likely to boost the growth of the market during the forecast period.
The global aminoglycosides market size was estimated at USD 7.1 billion in 2024 and is predicted to increase from USD 7.55 billion in 2025 to approximately USD 13.1 billion by 2034, expanding at a CAGR of 6.32% from 2025 to 2034. The growth of the market is driven by the increasing government funding in research and development activities aimed at infectious and bacterial diseases.
The global pancreatic cancer precision medicine market size accounted for USD 690.11 billion in 2024 and is predicted to increase from USD 823.30 million in 2025 to approximately USD 4,030.16 million by 2034, expanding at a CAGR of 19.30% from 2025 to 2034. The growing adoption of targeted therapies is the key factor driving the growth of the market. Also, the increasing shift towards precision medicine, coupled with the ongoing integration of bioinformatics and next-generation sequencing technologies, can fuel market growth further.
The immune monitoring solutions market is expected to grow at a CAGR of 13.00% from 2025 to 2034, driven by rising demand for precision immunology and diagnostics. The market is expanding due to the rising prevalence of diseases, immunotherapy advancements, and personalized medicine demand, driven by high-throughput sequencing, flow cytometry, and multiplex assays.
The oncology proteomics advances cancer research and precision medicine through biomarker discovery, protein analysis, and targeted therapies for improved patient outcomes. The growth of the market is driven by the rising burden of cancer worldwide and the increasing demand for personalized medicine.
The global colorado legal cannabis market size accounted for USD 2.65 billion in 2024 and is predicted to increase from USD 2.99 billion in 2025 to approximately USD 9.00 billion by 2034, expanding at a CAGR of 13.00% from 2025 to 2034. The growth of the market is driven by increased acceptance of cannabis in the medical field.
The global small molecule innovator CDMO market size was calculated at USD 53.07 billion in 2024 and is predicted to increase from USD 56.41 billion in 2025 to approximately USD 97.67 billion by 2034, expanding at a CAGR of 6.29% from 2025 to 2034. Increasing R&D investments are fuelling growth in the market, as pharmaceutical companies seek specialized partners for advanced development, regulatory compliance, and efficient manufacturing solutions.
The global dental implantology software market size accounted for USD 230.41 million in 2024 and is predicted to increase from USD 243.08 million in 2025 to approximately USD 393.57 million by 2034, expanding at a CAGR of 5.50% from 2025 to 2034. The excellent features driven by dental implantology software with accuracy, precision, and efficiency in clinical performance, ensuring promising surgical outcomes.
The global menstrual cup market size was estimated at USD 865.04 million in 2024 and is predicted to increase from USD 913.83 million in 2025 to approximately USD 1,497.34 million by 2034, expanding at a CAGR of 5.64% from 2025 to 2034. The growth of the market is attributed to the rising demand for sustainable feminine hygiene products, increased health consciousness, and growing acceptance of reusable menstrual care products.
The oral iron supplements market is growing as demand rises due to higher anemia rates, increased health consciousness, and broader healthcare accessibility. The market growth is attributed to the increased demand for safe, effective, and easily absorbable iron formulations across diverse age groups for treating health conditions like IDA.
India Class C and Class D medical devices market size accounted for USD 6.40 billion in 2024 and is predicted to increase from USD 6.82 billion in 2025 to approximately USD 12.57 billion by 2034, expanding at a CAGR of 7.00% from 2025 to 2034. The market shows rapid growth because of increased healthcare investment, government endorsement, heightened chronic illness statistics, and technological progress, which leads to the use of advanced medical products.
The global oral antibiotics market size accounted for USD 23.8 billion in 2024 and is predicted to increase from USD 24.43 billion in 2025 to approximately USD 30.89 billion by 2034, expanding at a CAGR of 2.64% from 2025 to 2034. The market is driven by rising bacterial infections, antibiotic resistance concerns, pharmaceutical innovations, and expanding healthcare access, fueling demand for advanced, effective, and accessible treatments worldwide.
The global over the counter (OTC) test market size accounted for USD 22.23 billion in 2024 and is predicted to increase from USD 24.69 billion in 2025 to approximately USD 63.35 billion by 2034, expanding at a CAGR of 11.04% from 2025 to 2034. The increasing need for rapid and effective testing solutions across the world is expected to boost the growth of the market during the forecast period.
The U.S. intra-abdominal pressure measurement devices market size accounted for USD 65.83 billion in 2024 and is predicted to increase from USD 71.26 billion in 2025 to approximately USD 147.57 billion by 2034, expanding at a CAGR of 8.41% from 2025 to 2034. The market growth is driven by the rising number of trauma incidences, ongoing advancements in medical device technologies and growing number of abdominal procedures in the U.S.
The global laboratory products and outsourcing services market size accounted for USD 38.6 billion in 2024 and is predicted to increase from USD 41.78 billion in 2025 to approximately USD 85.28 billion by 2034, expanding at a CAGR of 8.25% from 2025 to 2034. The rising occurrence of intricate diseases and the need for improved diagnostics are fueling expansion in the market. The increasing use of personalized medicine, non-invasive technologies, and outsourcing for cost-effectiveness and regulatory adherence also drives market growth.
The global monocyte activation test market size was accounted for USD 593.45 million in 2024 and is predicted to increase from USD 687.99 million in 2025 to approximately USD 2,602.21 million by 2034, expanding at a CAGR of 15.93% from 2025 to 2034. Growing awareness regarding ethical testing methods is the key factor driving market growth. Also, innovations in monocyte activation test (MAT) technology, coupled with the collaborations between market players, can fuel market growth soon.
The global apheresis equipment market size accounted for USD 3.21 billion in 2024 and is predicted to increase from USD 3.51 billion in 2025 to approximately USD 7.77 billion by 2034, expanding at a CAGR of 9.24% from 2025 to 2034. The increasing incidence of blood-related disorders is the key factor driving market growth. Also, technological advancements in apheresis devices coupled with the growing demand for blood components can fuel market growth further.
The global intra-abdominal pressure measurement devices market size accounted for USD 156.74 million in 2024 and is predicted to increase from USD 169.66 million in 2025 to approximately USD 345.99 million by 2034, expanding at a CAGR of 8.24% from 2025 to 2034. The market growth can be linked to the rising intra-abdominal incidences, ongoing research activities and growing demand for non-invasive procedures.
The global next-generation IVD market size accounted for USD 9.18 billion in 2024 and is predicted to increase from USD 9.69 billion in 2025 to approximately USD 15.61 billion by 2034, expanding at a CAGR of 5.45% from 2025 to 2034. Ongoing technological advancements, innovations in genomics, proteomics, and molecular diagnostics, and rising development of personalized and precision medical are driving the growth of the market.
The global genetic engineering market size was calculated at USD 1.62 billion in 2024 and is predicted to increase from USD 1.72 billion in 2025 to approximately USD 2.94 billion by 2034, expanding at a CAGR of 6.15% from 2025 to 2034. The growth of the market is driven by increasing government grants and funding to biotech startups. The rising production of vaccines and biologics further contributes to market growth.
The global dermatology excimer laser market size was estimated at USD 644.98 million in 2024 and is predicted to increase from USD 711.67 million in 2025 to approximately USD 1,725.35 million by 2034, expanding at a CAGR of 10.34% from 2025 to 2034. The growth of the dermatology excimer laser market is driven by the rising prevalence of skin diseases and high demand for cosmetic procedures.
The U.S. dental software market size was calculated at USD 490 million in 2024 and is predicted to increase from USD 540 million in 2025 to approximately USD 1,210 million by 2034, expanding at a CAGR of 9.46% from 2025 to 2034. Growing due increasing adoption of digital solutions for efficient practice management and improved patient care.
The global X-ray inspection system market size accounted for USD 2.55 billion in 2024 and is predicted to increase from USD 2.70 billion in 2025 to approximately USD 4.46 billion by 2034, expanding at a CAGR of 5.74% from 2025 to 2034. The market is predominantly fueled by growing security concerns, prompting airports, transportation hubs, and critical infrastructure facilities to make substantial investments in advanced X-ray technologies aimed at strengthening them.
The global leukapheresis devices market size accounted for USD 32.54 billion in 2024 and is predicted to increase from USD 35.12 billion in 2025 to approximately USD 70.01 billion by 2034, expanding at a CAGR of 7.97% from 2025 to 2034. The growing prevalence of leukemia is the key factor driving market growth. Also, technological innovations in leukapheresis procedures, coupled with the rising demand for personalized medicine, can fuel market growth further.
The global lithotripsy devices market size was calculated at USD 1.4 billion in 2024 and is predicted to increase from USD 1.5 billion in 2025 to approximately USD 2.62 billion by 2034, expanding at a CAGR of 6.44% from 2025 to 2034. The lithotripsy devices market is expected to grow at a rapid pace due to the rising government initiatives to boost the domestic production of medical devices.
The global live attenuated vaccines market size was estimated at USD 28.97 billion in 2024 and is predicted to increase from USD 32.17 billion in 2025 to approximately USD 82.63 billion by 2034, expanding at a CAGR of 11.05% from 2025 to 2034. The demand for market is increasing because of the surge in infectious diseases, worldwide vaccination initiatives and a transition to preventive healthcare. The market is anticipated to grow with an emphasis on non-invasive techniques such as intranasal vaccines.
The global rare cell isolation market size accounted for USD 2.05 billion in 2024 and is predicted to increase from USD 2.25 billion in 2025 to approximately USD 5.2 billion by 2034, expanding at a CAGR of 9.75% from 2025 to 2034. rising demand for precision medicine is expected to boost the growth of the market during the forecast period.
The global immunology biosimilars market size was calculated at USD 9.52 billion in 2024 and is predicted to increase from USD 11.23 billion in 2025 to approximately USD 49.61 billion by 2034, expanding at a CAGR of 17.95% from 2025 to 2034. The market is experiencing growth due to the increasing prevalence of chronic immunological diseases requiring immunotherapies, the increasing demand for cost-effective treatments, and the need for more accessible therapies by propelling the demand for immunology biosimilars.
The global peripheral blood mononuclear cells market size was calculated at USD 287.4 billion in 2024 and is predicted to increase from USD 317.35 billion in 2025 to approximately USD 774.41 billion by 2034, expanding at a CAGR of 10.42% from 2025 to 2034. The growth of the peripheral blood mononuclear cells market is attributed to the ongoing research activities for regenerative medicine and the rising development of immunotherapies. The rising demand for cell and gene therapies and a strong emphasis on the utilization of non-animal methods (NAMs) for material safety to expand next-generation risk assessment approaches (NGRA) support market growth.
The global xenotransplantation market size was estimated at USD 2.84 billion in 2024 and is predicted to increase from USD 3.12 billion in 2025 to approximately USD 7.26 billion by 2034, expanding at a CAGR of 9.84% from 2025 to 2034. An increase in cases of kidney and heart diseases around the world is expected to fuel the growth of the market during the forecast period.
The global perfusion systems market size accounted for USD 5.06 billion in 2024 and is predicted to increase from USD 5.64 billion in 2025 to approximately USD 15.03 billion by 2034, expanding at a CAGR of 11.50% from 2025 to 2034. Worldwide health infrastructure improvements, rising transplant volumes, increasing cardiovascular diseases, and research in pharmaceutical medicine sustain the consistent development of the market.
The global alkaptonuria therapeutics market size accounted for USD 15.10 million in 2024 and is predicted to increase from USD 16.19 million in 2025 to approximately USD 30.32 million by 2034, expanding at a CAGR of 7.22% from 2025 to 2034. The market growth is attributed to increasing research efforts, rising adoption of targeted therapies, and expanding rare disease awareness programs, driving early diagnosis and improved treatment accessibility.
The global dental matrix systems market size accounted for USD 420.16 million in 2024 and is predicted to increase from USD 445.37 million in 2025 to approximately USD 752.44 million by 2034, expanding at a CAGR of 6% from 2025 to 2034. The emerging need of people to recreate natural teeth and protect adjacent teeth by improving restoration longevity is expected to boost the growth of the dental matrix systems market during the forecast period.
The global refurbished dental equipment market size accounted for USD 1.05 billion in 2024 and is predicted to increase from USD 1.13 billion in 2025 to approximately USD 2.19 billion by 2034, expanding at a CAGR of 7.60% from 2025 to 2034. Refurbished dental equipment offers a cost-effective, eco-friendly solution for growing dental clinics. With rising dental visits and better quality checks, demand is increasing, making it a preferred choice for many professionals.
The global normothermic machine perfusion market size accounted for USD 1.71 billion in 2024 and is predicted to increase from USD 2.02 billion in 2025 to approximately USD 9.03 billion by 2034, expanding at a CAGR of 18.10% from 2025 to 2034. The market is driven by rising organ needs, technological advances with regulatory support. Furthermore, the growing understanding of NMP benefits is driving transplant clinics to become important success enhancers while prompting them to implement this technology more frequently.
The global prophy dental handpiece market size accounted for USD 244.12 million in 2024 and is predicted to increase from USD 258.28 million in 2025 to approximately USD 429 million by 2034, expanding at a CAGR of 5.80% from 2025 to 2034. The prophy dental handpiece market is growing due to increasing demand for preventive dental care. Furthermore, technological advancements and growing dental tourism contribute to market growth.
The global natural killer (NK) cell therapeutics market size was estimated at USD 340.25 million in 2024 and is predicted to increase from USD 477.10 million in 2025 to approximately USD 9,997.65 million by 2034, expanding at a CAGR of 40.22% from 2025 to 2034. The growth of the natural killer (NK) cell therapeutics market is driven by the rising mergers and acquisitions among biopharmaceutical companies, the potential for addressing unmet medical needs, and increased adoption and installation of advanced diagnostic platforms in various healthcare settings.
The global leukapheresis market size accounted for USD 219.47 million in 2024 and is predicted to increase from USD 243.83 million in 2025 to approximately USD 628.80 billion by 2034, expanding at a CAGR of 11.10% from 2025 to 2034. The rising incidence of blood disorders across the globe is the key factor driving the growth of the market. Also, technological innovations in leukapheresis procedures, coupled with the increasing need for personalized medicine, can fuel market growth further.
The global medical device clinical trials market size was calculated at USD 16.70 billion in 2024 and is predicted to increase from USD 17.74 billion in 2025 to approximately USD 30.53 billion by 2034, expanding at a CAGR of 6.22% from 2025 to 2034. The demand for medical device clinical trials is increasing due to the rising prevalence of chronic disease, which is driving advancements in the healthcare industry.
The global nitinol-based medical device market size was estimated at USD 4.66 billion in 2024 and is predicted to increase from USD 5.00 billion in 2025 to approximately USD 9.37 billion by 2034, expanding at a CAGR of 7.23% from 2025 to 2034. The market growth is driven by rising production of medical devices, ongoing technological advancements, and increasing healthcare expenditures.
The global medical device services market size was calculated at USD 17.77 billion in 2024 and is predicted to increase from USD 19.11 billion in 2025 to approximately USD 36.76 billion by 2034, expanding at a CAGR of 7.54% from 2025 to 2034. The market shows rapid growth due to technological progress and a customer need for advanced healthcare solutions of high quality.
The global medical metal tubing market size accounted for USD 756.46 million in 2024 and is predicted to increase from USD 812.59 million in 2025 to approximately USD 1,547.53 million by 2034, expanding at a CAGR of 7.42% from 2025 to 2034. The medical metal tubing market is growing rapidly due to the increasing government funding to improve healthcare infrastructure and the rising demand for medical devices.
The diabetes management technologies market is set to grow by 2034, driven by advancements in glucose monitoring, insulin delivery, and digital health solutions for better patient outcomes. The demand for self-management solutions has increased, driving the growth of the market. Technological advancements and digitalization are further fueling the adoption of management technologies. Additionally, the demand for personalized solutions boosts market expansion.
